Miller–Payne Grading and 70-Gene Signature Are Associated With Prognosis of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer After Neoadjuvant Chemotherapy

INTRODUCTION: HR+/HER2− breast cancer (BC) has a much lower pathological complete response (pCR) rate to neoadjuvant chemotherapy (NAC). Therefore, to better stratify the relapse risk for HR+/HER2− non-pCR populations, it is essential to accurate identification new prognostic markers. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liye, Luo, Rongzhen, Lu, Qianyi, Jiang, Kuikui, Hong, Ruoxi, Lee, Kaping, Zhang, Ping, Zhou, Danyang, Wang, Shusen, Xu, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498026/
https://www.ncbi.nlm.nih.gov/pubmed/34631568
http://dx.doi.org/10.3389/fonc.2021.735670

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498026/
https://www.ncbi.nlm.nih.gov/pubmed/34631568
http://dx.doi.org/10.3389/fonc.2021.735670

Ejemplares similares